Loading…
5 companies · GEL, thousands · columns ordered by revenue
Only 4 of 5 peers filed FY2024. Switch to FY2022 (5 of 5).
| Line item | Portres Parmasiutikal T… | Velpar Geo | Kordeksi | Konkordia West | Modern Medical Solutions |
|---|---|---|---|---|---|
| Total Revenue | 10,551 | 10,257 | 10,135 | 10,134 | — |
| Total COGS | -9,605 | -7,061 | -3,395 | -4,890 | — |
| Gross Profit | 946 | 3,196 | 6,739 | 5,243 | — |
| Gross Margin | 9.0% | 31.2% | 66.5% | 51.7% | — |
| Total Operating Expenses | -130 | -2,528 | -3,112 | -1,029 | — |
| EBITDA | 817 | 668 | 3,628 | 4,215 | — |
| EBITDA Margin | 7.7% | 6.5% | 35.8% | 41.6% | — |
| Total D&A | 0 | -47 | -79 | 0 | — |
| EBIT / Operating Income | 817 | 621 | 3,549 | 4,215 | — |
| Total Other Income | -372 | -821 | — | -58 | — |
| Profit Before Tax | 445 | -200 | 3,520 | 4,157 | — |
| Total Income Tax | 0 | -108 | 0 | -11 | — |
| Net Profit / (Loss) | 382 | -268 | 3,520 | 4,146 | — |
| Net Margin | 3.6% | -2.6% | 34.7% | 40.9% | — |
| Total Interest Expense | — | — | -29 | — | — |
Not every picked company reports every selected year — FY2024: no filing for Modern Medical Solutions. Those cells are left blank (no filing), not zero.
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Konkordia West | Pharma | 41.6% | 93rd pct | 110 |
| Kordeksi | Pharma | 35.8% | 85th pct | 110 |
| Portres Parmasiutikal T… | Pharma | 7.7% | 34th pct | 110 |
| Velpar Geo | Pharma | 6.5% | 27th pct | 110 |
| Modern Medical Solutions | Pharma | — | no FY data | 110 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.